ASCT2 knockdown was performed using two different shRNAs, shASCT2 28 (sh 28) and 63 (sh 63), in the two highest ASCT2-expressing endometrial cancer cell lines, Ishikawa and HEC1A. This evidence concerns the gene SLC1A5 and endometrial cancer.